Frequent inactivation of thep16 gene in human pituitary tumors by gene methylation
Authors:
- 1 August 1997
- journal article
- Published by Wiley in Molecular Carcinogenesis
- Vol. 19 (4) , 221-224
Abstract
Rodent models of pituitary tumorigenesis have implicated the retinoblastoma (Rb) pathway in the development of pituitary tumors. Previously, we reported that loss of p16 expression rather than loss of Rb occurs in most human pituitary adenomas. This alteration in these tumors is not associated with p16 mutation or frequent homozygous p16 gene loss. Our laboratory has now demonstrated that in most human pituitary tumors, the 5′ CpG island of the p16 gene is extensively methylated. The high frequency of p16 gene methylation in human pituitary tumors suggests that this alteration is an early and perhaps required event in pituitary cell transformation. Mol. Carcinog. 19:221–224, 1997.Keywords
This publication has 8 references indexed in Scilit:
- Abundance and state of phosphorylation of the retinoblastoma gene product in human pituitary tumorsInternational Journal of Cancer, 1996
- Alterations in DNA methylation may play a variety of roles in carcinogenesisCell, 1995
- Loss of heterozygosity at the retinoblastoma locus in human pituitary tumorsCancer, 1994
- Increased Cytosine DNA-Methyltransferase Activity During Colon Cancer ProgressionJNCI: Journal of the National Cancer Institute, 1993
- Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesisNature, 1992
- Effects of an Rb mutation in the mouseNature, 1992
- Requirement for a functional Rb-1 gene in murine developmentNature, 1992
- High expression of the DNA methyltransferase gene characterizes human neoplastic cells and progression stages of colon cancer.Proceedings of the National Academy of Sciences, 1991